Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Lawrence Steinman

Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (12)

Judith James

Member and Program Chair

Oklahoma Medical Research Foundation

UNITED STATES

View details

Douglas Arnold

Distinguished James McGill Professor

McGill University

CANADA

View details

Matthew Baker

Associate Professor of Medicine

Stanford University

UNITED STATES

View details

Nuria Alvarez Sanchez

Technologist II

Hospital for Sick Children

CANADA

View details

Ann Marshak-Rothstein

Professor

UMass Medical School

UNITED STATES

View details

Joseph J. Sabatino, Jr.

University of California, San Francisco

UNITED STATES

View details

William Robinson

James W. Raitt Professor of Medicine

Stanford University

UNITED STATES

View details

Raymond Sobel

Stanford University

UNITED STATES

View details

Mitchell Miglis

Stanford University

UNITED STATES

View details

Ludwig Kappos

Professor

University of Basel

SWITZERLAND

View details

Agnieszka Kalinowski

Clinical Assistant Professor

Stanford University

UNITED STATES

View details

Amit Bar-Or

Professor

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lawrence Steinman

Research Interests

Explore related searches

Articles (20)

Sjögren Syndrome Candidate Autoantigen AQP5 Triggers AQP4 CNS Autoimmunity Through Self-Antigen Mimicry.

From Molecular Mimicry to Clinical Laboratory: Longitudinal Measurement of EBNA1-Antibody Titers as a Diagnostic Biomarker of Multiple Sclerosis.

Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy.

Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosis.

EBV reprograms autoreactive anti-CNS B cells as antigen presenting cells in multiple sclerosis.

Peripheral complement C4 protein in schizophrenia: Association with gene copy number and immune cell subtypes

The complexity of interpreting TSPO PET neuroimaging in first-episode psychosis.

Why Is MS a More Frequent Complication of EBV Infection in Females?

“Home”

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics

Targeting Epstein–Barr virus is a viable therapeutic strategy in multiple sclerosis: Yes

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis.

Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study.

Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosis.

Postural Orthostatic Tachycardia Syndrome , Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials

Epstein-Barr virus reprograms autoreactive B cells as antigen presenting cells in systemic lupus erythematosus

Leveraging the immune milieu of experimental autoimmune encephalomyelitis to perpetuate an anti-tumor T cell response in glioblastoma

Five Years of Ublituximab in Relapsing Multiple Sclerosis: Additional Results from Open-label Extension of ULTIMATE I and II Studies

Collaborators (12)

Judith James

Douglas Arnold

Matthew Baker

Nuria Alvarez Sanchez

Ann Marshak-Rothstein

Joseph J. Sabatino, Jr.

William Robinson

Raymond Sobel

Mitchell Miglis

Ludwig Kappos

Agnieszka Kalinowski

Amit Bar-Or

Make your next move.